SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-134035
Filing Date
2022-04-29
Accepted
2022-04-29 16:43:24
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d304392d10ka.htm   iXBRL 10-K/A 520402
2 EX-31.3 d304392dex313.htm EX-31.3 3869
3 EX-31.4 d304392dex314.htm EX-31.4 3880
  Complete submission text file 0001193125-22-134035.txt   773655

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adgi-20211231.xsd EX-101.SCH 4679
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adgi-20211231_cal.xml EX-101.CAL 673
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adgi-20211231_def.xml EX-101.DEF 1678
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE adgi-20211231_lab.xml EX-101.LAB 21700
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adgi-20211231_pre.xml EX-101.PRE 17522
10 EXTRACTED XBRL INSTANCE DOCUMENT d304392d10ka_htm.xml XML 5825
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40703 | Film No.: 22876502
SIC: 2836 Biological Products, (No Diagnostic Substances)